AS-138: Are There Differences in Clinical Outcomes after Target Lesion Revascularization for Restenosis According to the Type of Restenosed Drug-Eluting Stent? Comparisons between Sirolimus- versus Paclitaxel-Eluting Stent Restenosis - 11/08/11
Doi : 10.1016/j.amjcard.2009.01.194
Byeung-Keuk Kim 1, Seung Jin Oh 1, Dong Woon Jeon 1, Joo Young Yang 1, Jung-Sun Kim 2, Young-Guk Ko 2, Donghoon Choi 2, Yangsoo Jang 2, Bum-Kee Hong 3, Hyuk Moon Kwon 3, Seung-Whan Lee 4, Kihwan Kwon 5, Jae-Hun Jung 6, Choong Won Goh 7
1 National Health Insurance Corporation Ilsan Hospital, Goyang-si, Republic of Korea
2 Yonsei University Severance Hospital, Seoul, Republic of Korea
3 Yonsei University Yongdong Severance Hospital, Seoul, Republic of Korea
4 Yonsei University Wonju Christian Hospital, Wonju, Republic of Korea
5 Ehwa Woman's University Mokdong Hospital, Seoul, Republic of Korea
6 Hallym University Kangnam Sacred Hospital, Seoul, Republic of Korea
7 Inje University Sanggye Paik Hospital, Seoul, Republic of Korea
Le texte complet de cet article est disponible en PDF.
Plan
© 2009
Elsevier Inc. Tous droits réservés.
Vol 103 - N° 9S
P. 62B - avril 2009 Retour au numéro
Article précédent
- AS-137: Comparison of Long-Term Clinical Outcomes following Sirolimus-Eluting Stent Implantation in Lesions with Proximal Left Anterior Descending versus Proximal Left Circumflex and Right Coronary Arteries
- Hyoung-Seob Park, J.-Hyun Sohn, In-Cheol Kim, Hyun-Tae Kim, Yun-Kyeong Cho, Hyuck-Jun Yoon, Hyungseop Kim, Chang-Wook Nam, Seong-Wook Han, Seung-Ho Hur, Yoon-Nyun Kim, Kwon-Bae Kim
- AS-139: Impact of Treatment Strategy on Target Vessel Revascularization Rate in Coronary Bifurcation Lesions
- Indulis Kumsars, I. Narbute, D. Sondore, A. Dombrovskis, A. Lismanis, K. Trusinskis, S. Jegere, G. Kucika, A. Erglis
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?